Gain Therapeutics Inc (GANX) — Financial Flexibility Index
Gain Therapeutics Inc (GANX) has a Financial Flexibility Index of -1.09x as of December 2025. Free cash flow of $-4.62 Million (operating CF $-4.62 Million minus capex $3.00) represents -1% of total liabilities ($4.25 Million). Check Gain Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gain Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Gain Therapeutics Inc across 8 annual periods. See working capital position of Gain Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Gain Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Gain Therapeutics Inc. For the full company profile including market capitalisation, see Gain Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.34x | $-18.47 Million | $-18.47 Million | $4.25 Million | ▼ -10.2% |
| 2024 | -3.94x | $-18.85 Million | $-18.87 Million | $4.78 Million | ▼ -26.1% |
| 2023 | -3.13x | $-18.85 Million | $-18.87 Million | $6.03 Million | ▼ -12.0% |
| 2022 | -2.79x | $-14.57 Million | $-14.69 Million | $5.22 Million | ▲ +5.2% |
| 2021 | -2.94x | $-12.27 Million | $-12.37 Million | $4.17 Million | ▼ -211.2% |
| 2020 | -0.95x | $-3.22 Million | $-3.24 Million | $3.40 Million | ▲ +43.4% |
| 2019 | -1.67x | $-1.85 Million | $-1.87 Million | $1.11 Million | ▼ -299.8% |
| 2018 | -0.42x | $-736.53K | $-744.51K | $1.76 Million | — |